Cargando…

Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature

BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterine neoplasm characterized by a benign, but occasionally atypi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrelli, Tito Silvio, Gizzo, Salvatore, Di Gangi, Stefania, Guidi, Giorgia, Rondinelli, Mario, Nardelli, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141764/
https://www.ncbi.nlm.nih.gov/pubmed/21663687
http://dx.doi.org/10.1186/1471-2407-11-236
_version_ 1782208751297626112
author Patrelli, Tito Silvio
Gizzo, Salvatore
Di Gangi, Stefania
Guidi, Giorgia
Rondinelli, Mario
Nardelli, Giovanni Battista
author_facet Patrelli, Tito Silvio
Gizzo, Salvatore
Di Gangi, Stefania
Guidi, Giorgia
Rondinelli, Mario
Nardelli, Giovanni Battista
author_sort Patrelli, Tito Silvio
collection PubMed
description BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterine neoplasm characterized by a benign, but occasionally atypical, epithelial and a malignant, usually low-grade, stromal component, both of which should be integral and neoplastic constituents of the tumor. Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a very aggressive variant, associated with post-operative recurrence, metastases, even when diagnosed in early stage. CASE PRESENTATION: We present a fourth MASO case derived from uterine cervix in a 72-year-old woman with metrorrhagia and a polypoid mass protruding through the cervical ostium. Total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic lymph node dissection, omental biopsy and appendectomy were performed. Surgery treatment was associated with adjuvant whole-pelvis radiation (45 Gy) and adjuvant chemotherapy (cisplatin/ifosfamide). After nine months of follow up, the patient was free of tumor. CONCLUSIONS: The rarity of MASO of the cervix involves a management difficult. Most authors recommend total abdominal hysterectomy, usually accompanied by bilateral salpingo-oophorectomy. There is no common agreement on staging by lymphadenectomy during primary surgery and adjuvant chemo-radio therapy.
format Online
Article
Text
id pubmed-3141764
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31417642011-07-23 Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature Patrelli, Tito Silvio Gizzo, Salvatore Di Gangi, Stefania Guidi, Giorgia Rondinelli, Mario Nardelli, Giovanni Battista BMC Cancer Case Report BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterine neoplasm characterized by a benign, but occasionally atypical, epithelial and a malignant, usually low-grade, stromal component, both of which should be integral and neoplastic constituents of the tumor. Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a very aggressive variant, associated with post-operative recurrence, metastases, even when diagnosed in early stage. CASE PRESENTATION: We present a fourth MASO case derived from uterine cervix in a 72-year-old woman with metrorrhagia and a polypoid mass protruding through the cervical ostium. Total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic lymph node dissection, omental biopsy and appendectomy were performed. Surgery treatment was associated with adjuvant whole-pelvis radiation (45 Gy) and adjuvant chemotherapy (cisplatin/ifosfamide). After nine months of follow up, the patient was free of tumor. CONCLUSIONS: The rarity of MASO of the cervix involves a management difficult. Most authors recommend total abdominal hysterectomy, usually accompanied by bilateral salpingo-oophorectomy. There is no common agreement on staging by lymphadenectomy during primary surgery and adjuvant chemo-radio therapy. BioMed Central 2011-06-11 /pmc/articles/PMC3141764/ /pubmed/21663687 http://dx.doi.org/10.1186/1471-2407-11-236 Text en Copyright ©2011 Patrelli et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Patrelli, Tito Silvio
Gizzo, Salvatore
Di Gangi, Stefania
Guidi, Giorgia
Rondinelli, Mario
Nardelli, Giovanni Battista
Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
title Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
title_full Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
title_fullStr Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
title_full_unstemmed Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
title_short Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
title_sort cervical mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141764/
https://www.ncbi.nlm.nih.gov/pubmed/21663687
http://dx.doi.org/10.1186/1471-2407-11-236
work_keys_str_mv AT patrellititosilvio cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature
AT gizzosalvatore cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature
AT digangistefania cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature
AT guidigiorgia cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature
AT rondinellimario cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature
AT nardelligiovannibattista cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature